TODD STRATEGY GROUP

Lobbying for BIODESIX, INC. · Fully integrated molecular diagnostic company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Colorado · House · Senate · $30,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Medicare/Medicaid

Medicare reimbursement for diagnostics. Medicare Contractor Reform.

Health Issues

Lab test regulatory and reimbursement reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.